Chitosan nanoparticle based ΔgE IBRV Vaccine: A Novel DIVA compatible strategy for enhanced immunity in guinea pigs

Key Points

• Enhanced immunity observed with the chitosan-based vaccine formulation, indicating potential for DIVA compatibility.
• The primary outcome focused on immunity levels post-vaccination measured through specific immune responses.
• Assessment involved a comprehensive analysis of vaccine efficacy in guinea pigs through controlled exposure trials.
• Highlights the need for further validation of this strategy to enhance immunization approaches against IBRV.